Literature DB >> 34760597

Accuracy of point-of-care intestinal ultrasound for Crohn's disease.

Emily K Wright1,2, Ian Wang1, Darren Wong1,2, Sally J Bell1, William R Connell1, Alexander J Thompson1,2, Kerri L Novak3, Michael A Kamm1,2.   

Abstract

BACKGROUND: Point-of-care ultrasound (POCUS), performed by a gastroenterologist, provides safe and convenient imaging allowing for immediate clinical decision in Crohn's disease. The minimum training required to gain competency, its accuracy and clinical utility requires evaluation.
METHODS: In this pilot study, Crohn's disease activity and extent were assessed using POCUS (performed by a single gastroenterologist following the completion of 200 supervised scans), magnetic resonance enterography (MRE) and ileo-colonoscopy. The presence of complications was assessed by POCUS and MRE. Accuracy of POCUS was analysed with respect to MRE and ileo-colonoscopy. Agreement between modalities was assessed using kappa coefficient.
RESULTS: Forty-two patients had a POCUS paired with MRE. Thirty-eight patients had a POCUS paired with ileo-colonoscopy. When compared to MRE, POCUS was accurate in the assessment of disease activity (sensitivity 87.5%, specificity 61.1%, ROC 0.74), extent (sensitivity 77.8%, specificity 83.3%, ROC 0.81) and complications (sensitivity 85.7%, specificity 94.3%, ROC 0.90). Agreement between POCUS and MRE was moderate (kappa estimates 0.50, P < 0.001, 0.61, P < 0.001 and 0.76, P < 0.001) for disease activity, extent and complications, respectively. When compared to ileo-colonoscopy, POCUS was accurate in the assessment of disease activity (sensitivity 72%, specificity 86%, ROC 0.79) and extent (sensitivity 85.7%, specificity 86%, ROC 0.86). For POCUS and ileo-colonoscopy, kappa estimates were 0.55, P < 0.001 for disease activity and 0.62, P < 0.001 for disease extent.
CONCLUSION: POCUS performed by a gastroenterologist after completion of limited training is accurate for assessing Crohn's disease activity, extent and the presence of complications.
© 2020 Australasian Society for Ultrasound in Medicine.

Entities:  

Keywords:  Crohn's disease; GIUS; POCUS; intestinal ultrasound

Year:  2020        PMID: 34760597      PMCID: PMC8411776          DOI: 10.1002/ajum.12218

Source DB:  PubMed          Journal:  Australas J Ultrasound Med        ISSN: 1836-6864


  34 in total

Review 1.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

2.  Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's Disease.

Authors:  Anthony Buisson; Constance Hordonneau; Parakkal Deepak
Journal:  Inflamm Bowel Dis       Date:  2017-09       Impact factor: 5.325

Review 3.  WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice.

Authors:  Nathan S S Atkinson; Robert V Bryant; Yi Dong; Christian Maaser; Torsten Kucharzik; Giovanni Maconi; Anil K Asthana; Michael Blaivas; Adrian Goudie; Odd Helge Gilja; Christian Nolsøe; Dieter Nürnberg; Christoph F Dietrich
Journal:  Ultrasound Med Biol       Date:  2016-10-11       Impact factor: 2.998

4.  Detection of Crohn's disease by ultrasound.

Authors:  A Sonnenberg; J Erckenbrecht; P Peter; C Niederau
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

5.  Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics.

Authors:  Fabiana Castiglione; Anna Testa; Matilde Rea; Giovanni Domenico De Palma; Maria Diaferia; Dario Musto; Francesca Sasso; Nicola Caporaso; Antonio Rispo
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

6.  Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease.

Authors:  S Chatu; V Subramanian; R C G Pollok
Journal:  Aliment Pharmacol Ther       Date:  2012-01-13       Impact factor: 8.171

7.  Role of US in detection of Crohn disease: meta-analysis.

Authors:  Mirella Fraquelli; Agostino Colli; Giovanni Casazza; Silvia Paggi; Alice Colucci; Sara Massironi; Piergiorgio Duca; Dario Conte
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

Review 8.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

Review 9.  Ultrasound as a diagnostic tool in detecting active Crohn's disease: a meta-analysis of prospective studies.

Authors:  Jianning Dong; Honggang Wang; Jie Zhao; Weiming Zhu; Liang Zhang; Jianfeng Gong; Yi Li; Lili Gu; Jieshou Li
Journal:  Eur Radiol       Date:  2013-08-07       Impact factor: 5.315

10.  Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea.

Authors:  Kerri L Novak; Deepti Jacob; Gilaad G Kaplan; Emma Boyce; Subrata Ghosh; Irene Ma; Cathy Lu; Stephanie Wilson; Remo Panaccione
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.